Aims: Stem cells are a new hope to ameliorate impaired diabetic wound healing. The purpose of this study was to evaluate the effect of adipose tissue derived mesenchymal stem cells (AD-MSCs) on wound healing in a diabetic rat model.
Methods: Twenty-six rats became diabetic by a single intraperitoneal injection of streptozotocin.